Alexion Pharmaceuticals Given "Outperform" Rating by Leerink Swann Analysts (ALXN) Web Inquirer ... development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeutic areas of hematology, nephrology (including transplant rejection), neurology, ... |
